{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:37:38Z","timestamp":1788910658573,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Project of Key Research and Development Plan of Shaanxi","award":["2023YBSF424"],"award-info":[{"award-number":["2023YBSF424"]}]},{"name":"\u201cPhoenix Introduction Plan\u201d Project of Tangdu Hospital, Air Force Military Medical University","award":["2022YFJH007"],"award-info":[{"award-number":["2022YFJH007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The combined effect of obesity and metabolic abnormalities on liver injury is unclear. Aiming to address this knowledge gap, this cross-sectional study was conducted among 16,201 US adults. Multiple linear regression and logistic regression analyses were conducted to assess the associations of obesity profiles, metabolic health status, and weight change with the levels of liver enzymes. The analysis revealed that general obesity and abdominal obesity were positively associated with the levels of liver enzymes and the prevalence of abnormal liver enzymes (<jats:italic>P<\/jats:italic>and<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&lt;\u20090.05). The associations remained significant in both metabolically healthy and metabolically unhealthy subgroups. Additionally, the liver injury index levels of the metabolically unhealthy participants were higher than those of the metabolically healthy individuals within the non-obese, overweight\/pre-abdominal obesity, and general\/abdominal obesity subgroups (<jats:italic>P<\/jats:italic>and<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&lt;\u20090.05). Furthermore, the subgroup characterized by general\/abdominal obesity and metabolic dysfunction exhibited the most robust association with the liver injury index compared to all other subgroups examined. In addition, positive associations were observed between the 1-year and 10-year weight changes and the levels of liver injury indicators (<jats:italic>P<\/jats:italic>and<jats:italic>P<\/jats:italic><jats:sub>trend<\/jats:sub>\u2009&lt;\u20090.05). In conclusion, this study demonstrates that both obesity and metabolic impairment are independently associated with liver injury, and their combined presence have an additional adverse effect on liver health. These findings underscore the importance of addressing both obesity and metabolic dysfunction in order to mitigate the risk of liver injury.<\/jats:p>","DOI":"10.1038\/s41598-023-43028-7","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T10:02:23Z","timestamp":1695636143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of obesity profiles and metabolic health status with liver injury among US adult population in NHANES 1999\u20132016"],"prefix":"10.1038","volume":"13","author":[{"given":"Jing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huinan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"issue":"21","key":"43028_CR1","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts, E., Gannon, M. & Wasserman, D. H. The liver. Curr. Biol. 27(21), R1147\u2013R1151 (2017).","journal-title":"Curr. Biol."},{"issue":"1","key":"43028_CR2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao, J. et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J. Hepatol. 71(1), 212\u2013221 (2019).","journal-title":"J. Hepatol."},{"issue":"5","key":"43028_CR3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik, J. M., Golabi, P., Younossi, Y., Mishra, A. & Younossi, Z. M. Changes in the global burden of chronic liver diseases from 2012 to 2017: The growing impact of NAFLD. Hepatology 72(5), 1605\u20131616 (2020).","journal-title":"Hepatology"},{"issue":"10159","key":"43028_CR4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"Collaborators GDaIIaP","year":"2018","unstructured":"Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1789\u20131858 (2018).","journal-title":"Lancet"},{"issue":"5","key":"43028_CR5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology 71(5), 1851\u20131864 (2020).","journal-title":"Hepatology"},{"key":"43028_CR6","doi-asserted-by":"crossref","first-page":"126497","DOI":"10.1016\/j.jhazmat.2021.126497","volume":"419","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Systemic inflammation mediates the association of heavy metal exposures with liver injury: A study in general Chinese urban adults. J. Hazard Mater. 419, 126497 (2021).","journal-title":"J. Hazard Mater."},{"issue":"1","key":"43028_CR7","doi-asserted-by":"crossref","first-page":"60343","DOI":"10.1007\/s11356-023-26702-1","volume":"30","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Lipid peroxidation mediates the association between iron overload and liver injury: Cross-sectional and longitudinal analyses in general Chinese urban adults. Environ. Sci. Pollut. Res. Int. 30(1), 60343\u201360353 (2023).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"2","key":"43028_CR8","doi-asserted-by":"crossref","first-page":"e12581","DOI":"10.1111\/ijpo.12581","volume":"15","author":"A Seth","year":"2020","unstructured":"Seth, A. et al. Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. Pediatr. Obes. 15(2), e12581 (2020).","journal-title":"Pediatr. Obes."},{"issue":"10","key":"43028_CR9","doi-asserted-by":"crossref","first-page":"e1008405","DOI":"10.1371\/journal.pgen.1008405","volume":"15","author":"JC Censin","year":"2019","unstructured":"Censin, J. C. et al. Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet. 15(10), e1008405 (2019).","journal-title":"PLoS Genet."},{"issue":"3","key":"43028_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1467-789X.2011.00944.x","volume":"13","author":"B Xi","year":"2012","unstructured":"Xi, B. et al. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993\u20132009. Obes. Rev. 13(3), 287\u2013296 (2012).","journal-title":"Obes. Rev."},{"issue":"1","key":"43028_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000502478","volume":"9","author":"J Rahmani","year":"2020","unstructured":"Rahmani, J. et al. Waist circumference and risk of liver cancer: A systematic review and meta-analysis of over 2 million cohort study participants. Liver Cancer 9(1), 6\u201314 (2020).","journal-title":"Liver Cancer"},{"issue":"1","key":"43028_CR12","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1038\/s41598-021-86216-z","volume":"11","author":"N Ali","year":"2021","unstructured":"Ali, N. et al. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Sci. Rep. 11(1), 6640 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"43028_CR13","doi-asserted-by":"crossref","first-page":"dgz010","DOI":"10.1210\/clinem\/dgz010","volume":"105","author":"MJ Johansen","year":"2020","unstructured":"Johansen, M. J. et al. The effect of overweight and obesity on liver biochemical markers in children and adolescents. J. Clin. Endocrinol. Metab. 105(2), dgz010 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"43028_CR14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki, N., Mikhailidis, D. P. & Mantzoros, C. S. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 65(8), 1109\u20131123 (2016).","journal-title":"Metabolism"},{"key":"43028_CR15","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren, J. & Scheja, L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol. Metab. 50, 101238 (2021).","journal-title":"Mol. Metab."},{"issue":"1","key":"43028_CR16","doi-asserted-by":"crossref","first-page":"15581","DOI":"10.1038\/s41598-022-20084-z","volume":"12","author":"F \u00c5berg","year":"2022","unstructured":"\u00c5berg, F. et al. Association between arterial hypertension and liver outcomes using polygenic risk scores: A population-based study. Sci. Rep. 12(1), 15581 (2022).","journal-title":"Sci. Rep."},{"issue":"1","key":"43028_CR17","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.orcp.2012.08.191","volume":"8","author":"L Elizondo-Montemayor","year":"2014","unstructured":"Elizondo-Montemayor, L. et al. Association of ALT and the metabolic syndrome among Mexican children. Obes. Res. Clin. Pract. 8(1), e79\u2013e87 (2014).","journal-title":"Obes. Res. Clin. Pract."},{"issue":"3","key":"43028_CR18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","volume":"77","author":"J Xie","year":"2023","unstructured":"Xie, J. et al. The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study. Hepatology 77(3), 949\u2013964 (2023).","journal-title":"Hepatology"},{"issue":"3","key":"43028_CR19","doi-asserted-by":"crossref","first-page":"e13912","DOI":"10.1111\/eci.13912","volume":"53","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Relationship between obesity severity, metabolic status and cardiovascular disease in obese adults. Eur. J. Clin. Invest. 53(3), e13912 (2023).","journal-title":"Eur. J. Clin. Invest."},{"issue":"4","key":"43028_CR20","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung, U. J. & Choi, M.-S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 15(4), 6184\u20136223 (2014).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"43028_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest. 127(1), 1\u20134 (2017).","journal-title":"J. Clin. Invest."},{"issue":"3","key":"43028_CR22","doi-asserted-by":"crossref","first-page":"bnna004","DOI":"10.1210\/endrev\/bnaa004","volume":"41","author":"M Bl\u00fcher","year":"2020","unstructured":"Bl\u00fcher, M. Metabolically healthy obesity. Endocr. Rev. 41(3), bnna004 (2020).","journal-title":"Endocr. Rev."},{"issue":"7","key":"43028_CR23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/dc20-2227","volume":"44","author":"Y Commodore-Mensah","year":"2021","unstructured":"Commodore-Mensah, Y. et al. High burden of subclinical and cardiovascular disease risk in adults with metabolically healthy obesity: The atherosclerosis risk in communities (ARIC) study. Diabetes Care 44(7), 1657\u20131663 (2021).","journal-title":"Diabetes Care"},{"key":"43028_CR24","doi-asserted-by":"crossref","first-page":"106608","DOI":"10.1016\/j.envint.2021.106608","volume":"155","author":"L Yu","year":"2021","unstructured":"Yu, L. et al. Associations between urinary phthalate metabolite concentrations and markers of liver injury in the US adult population. Environ. Int. 155, 106608 (2021).","journal-title":"Environ. Int."},{"key":"43028_CR25","doi-asserted-by":"crossref","first-page":"l5584","DOI":"10.1136\/bmj.l5584","volume":"367","author":"C Chen","year":"2019","unstructured":"Chen, C., Ye, Y., Zhang, Y., Pan, X.-F. & Pan, A. Weight change across adulthood in relation to all cause and cause specific mortality: Prospective cohort study. BMJ 367, l5584 (2019).","journal-title":"BMJ"},{"issue":"28","key":"43028_CR26","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehx140","volume":"38","author":"SC Larsson","year":"2017","unstructured":"Larsson, S. C., Wolk, A., H\u00e5kansson, N. & B\u00e4ck, M. Overall and abdominal obesity and incident aortic valve stenosis: Two prospective cohort studies. Eur. Heart J. 38(28), 2192\u20132197 (2017).","journal-title":"Eur. Heart J."},{"issue":"6","key":"43028_CR27","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.27367","volume":"60","author":"Q Xiao","year":"2014","unstructured":"Xiao, Q., Sinha, R., Graubard, B. I. & Freedman, N. D. Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999\u20132010. Hepatology 60(6), 2091\u20132098 (2014).","journal-title":"Hepatology"},{"issue":"1","key":"43028_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","volume":"112","author":"PY Kwo","year":"2017","unstructured":"Kwo, P. Y., Cohen, S. M. & Lim, J. K. ACG clinical guideline: Evaluation of abnormal liver chemistries. Am. J. Gastroenterol. 112(1), 18\u201335 (2017).","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"43028_CR29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","volume":"47","author":"WR Kim","year":"2008","unstructured":"Kim, W. R., Flamm, S. L., Di Bisceglie, A. M. & Bodenheimer, H. C. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47(4), 1363\u20131370 (2008).","journal-title":"Hepatology"},{"issue":"3","key":"43028_CR30","doi-asserted-by":"crossref","first-page":"e190305","DOI":"10.1001\/jamanetworkopen.2019.0305","volume":"2","author":"AR Carter","year":"2019","unstructured":"Carter, A. R. et al. Combined association of body mass index and alcohol consumption with biomarkers for liver injury and incidence of liver disease: A Mendelian randomization study. JAMA Netw. Open. 2(3), e190305 (2019).","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"43028_CR31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.24097","volume":"53","author":"OT Ayonrinde","year":"2011","unstructured":"Ayonrinde, O. T. et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 53(3), 800\u2013809 (2011).","journal-title":"Hepatology"},{"key":"43028_CR32","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Primers. 1, 15080 (2015).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"28","key":"43028_CR33","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107, S., Luli\u0107, D. & \u0160timac, D. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations. World J. Gastroenterol. 20(28), 9330\u20139337 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"43028_CR34","doi-asserted-by":"crossref","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","volume":"8","author":"R Fan","year":"2018","unstructured":"Fan, R., Wang, J. & Du, J. Association between body mass index and fatty liver risk: A dose-response analysis. Sci. Rep. 8(1), 15273 (2018).","journal-title":"Sci. Rep."},{"issue":"12","key":"43028_CR35","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/liv.15053","volume":"41","author":"O Danielsson","year":"2021","unstructured":"Danielsson, O. et al. Waist and hip circumference are independently associated with the risk of liver disease in population-based studies. Liver Int. 41(12), 2903\u20132913 (2021).","journal-title":"Liver Int."},{"issue":"1","key":"43028_CR36","doi-asserted-by":"crossref","first-page":"e2006972","DOI":"10.1371\/journal.pbio.2006972","volume":"17","author":"F Manzano-N\u00fa\u00f1ez","year":"2019","unstructured":"Manzano-N\u00fa\u00f1ez, F. et al. Insulin resistance disrupts epithelial repair and niche-progenitor Fgf signaling during chronic liver injury. PLoS Biol. 17(1), e2006972 (2019).","journal-title":"PLoS Biol."},{"issue":"17","key":"43028_CR37","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","volume":"16","author":"E Bugianesi","year":"2010","unstructured":"Bugianesi, E., Moscatiello, S., Ciaravella, M. F. & Marchesini, G. Insulin resistance in nonalcoholic fatty liver disease. Curr. Pharm. Des. 16(17), 1941\u20131951 (2010).","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"43028_CR38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3892\/ijmm.2013.1544","volume":"33","author":"S Arima","year":"2014","unstructured":"Arima, S. et al. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. Int. J. Mol. Med. 33(1), 68\u201376 (2014).","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"43028_CR39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","volume":"111","author":"Y Chang","year":"2016","unstructured":"Chang, Y. et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 111(8), 1133\u20131140 (2016).","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"43028_CR40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1463-1326.2011.01497.x","volume":"14","author":"NE Straznicky","year":"2012","unstructured":"Straznicky, N. E. et al. The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects. Diabetes Obes. Metab. 14(2), 139\u2013148 (2012).","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"43028_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-148-5-200803040-00005","volume":"148","author":"M Lazo","year":"2008","unstructured":"Lazo, M., Selvin, E. & Clark, J. M. Brief communication: Clinical implications of short-term variability in liver function test results. Ann. Intern. Med. 148(5), 348\u2013352 (2008).","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"43028_CR42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/apt.12923","volume":"40","author":"N Husain","year":"2014","unstructured":"Husain, N. et al. Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: Development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol. Ther. 40(8), 949\u2013954 (2014).","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43028-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T22:19:18Z","timestamp":1730153958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43028"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43028-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15958"}}